News

Palvella begins its phase 2 TOIVA trial of Qtorin rapamycin gel for cutaneous venous malformations, targeting the mTOR pathway.

Experts explore innovative therapies, psychosocial impacts, and education strategies for managing atopic dermatitis in a Dermatology Times video series.

A Finnish review highlights imprecise use of L23.8 and L23.9 codes for allergic contact dermatitis.

While zinc deficiency shows strong ties to SD, researchers stated vitamin D's role is less clear and may depend on genetic factors.

The stable preparation combined vitamin C and hyaluronic acid with complexed ubiquinone in this initial study.

Explore systemic psoriasis management, covering obesity, depression, biologics, and innovative treatment approaches.

By addressing skin health proactively, runners can enhance performance and longevity in the sport while minimizing discomfort and long-term dermatological damage.

With further research, plants such as licorice, tomato, and parsley, could eventually be promising alternatives for melasma patients.

Christopher Bunick, MD, PhD, is an associate professor of dermatology and physician-scientist at Yale School of Medicine in New Haven, Connecticut.

The HA filler with tri-hyal technology reduced wrinkles on the forehead, upper lip, cheek folds, and crow’s feet for up to 18 months.

Share your insights and anticipation with us.

Repibresib’s localized delivery minimizes systemic exposure while targeting inflammatory pathways, a novel approach for vitiligo management.

The results showed promising improvements in all endpoints with high patient satisfaction and no safety concerns.

More improved skin hydration and barrier function was observed in moisturizers with anti-inflammatory ingredients, compared to those without.

The FDA recently proposed a new rule requiring standardized asbestos testing in talc-containing cosmetics to protect consumers from potential harm.

In case you missed it, this week we had news about a significant dual treatment approach for AD, organic filter-based sunscreens for sensitive skin, what we’re most looking forward to in 2025, and more.

Explore the top headlines of the week including 2025 PDUFA dates, 2024 interview insights, and awareness dates to add to your calendar.

After 8 weeks of use, the product showed improvements in skin sensitivity, transepidermal water loss, and skin corneum hydration.

We're welcoming 2025 with dermatology innovations, expert insights on chronic hand eczema, and new leadership at Dermatology Times.

Real-world data from TARGET-DERM AD revealed that those with both reduced itch and clearer skin had the lowest levels of disease burden.

Unlike bakuchiol, which exhibited toxicity at higher concentrations, SME demonstrated no cytotoxic effects in vitro.

The dermatology market remains an exciting space with strong demand for its valuable services, bolstered by positive US economic trends and robust consumer spending.

Researchers found significant clinical benefits and tolerability with dual therapy for patients unresponsive to dupilumab alone.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of January.

Dermatology Times asked our readers to share what conferences they are looking forward to in 2025.

Click here to view Dermatology Times' comprehensive list of health awareness days, months, weeks, and initiatives for 2025.

Experts in the field shared insights with Dermatology Times on what they're looking forward to most in the new year.

Dermatology Times is reviewing some of the most anticipated PDUFA dates of the upcoming year.

Explore the standout moments and expert insights from Dermatology Times' Cutaneous Connection podcast episodes in 2024.

Discover the most impactful insights and expert advice from Dermatology Times' 2024 Interview Intersection column.